China city Beijing virus covid-19 vaccine China city Beijing

First human trial of SARS-CoV-2 vaccine: Initial results in

Reading now: 395
www.medicalnewstoday.com

Researchers from China report the initial findings of the first human trial for a potential vaccine against SARS-CoV-2, the new coronavirus.

The results are promising, suggesting that the vaccine is mostly safe and apparently effective. At present, there are numerous clinical trials around the world testing potential vaccines against the new coronavirus, SARS-CoV-2.

The first human trial for such a vaccine started in early March. It is the work of researchers from several Chinese institutions, including the China National Institute for Food and Drug Control in Beijing, the Beijing Institute of Biotechnology, and the Chinese vaccine company CanSino Biologics.

Read more on medicalnewstoday.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA